摘要
背景:免疫球蛋白G和A、转铁蛋白、触珠蛋白和α-1-抗胰蛋白酶约占人类血清糖蛋白组的85%,它们的N-糖基化分析可能有助于发现重要的疾病分子标记物。然而,由于唾液酸残基的不稳定性,血清N-糖蛋白组的去烷基亚群传统上被用于诊断应用。 目的:创建一个五蛋白模型来拆析肺部炎症和恶性疾病的整体n -糖基化指纹。 方法:分析了人血清的N-聚糖库和5种高含量的血清糖蛋白。同时内糖苷酶/唾液酸酶消化,荧光标记,CE-LIF分离建立模型。我们分析了来自COPD、肺癌(LC)及其共病患者的混合血清样本。 结果:9个显著的(>1%)缺乏唾液酸基的-N-聚糖结构在人血清和标准蛋白混合物中被鉴定出来。核心聚焦的半乳半乳糖双聚糖分化了COPD和LC,并分别来自对照组和共病组。核心聚焦的无乳-双胎-二分,单乳和双乳结构的减少将所有疾病组与对照组区分开来。聚焦化半乳糖化三胎儿结构的显著增加对LC是高度特异性的,对COPD是中等程度的,对共病是较小程度的。此外,与对照组相比,所有三种疾病类型的无聚焦-半乳糖化-双触角结构以及COPD和LC的无聚焦-半乳糖化-三触角结构均有所增加。 结论:我们的结果表明,脱盐的人血清N-glycome的变化具有糖蛋白特异性分子诊断恶性和炎症性肺部疾病的潜力,这可以用五蛋白混合物建模。
关键词: 人血清N-糖基化,去硅烷基化,毛细管电泳,肺疾病,分子诊断,恶性
Current Molecular Medicine
Title:Modeling of the Desialylated Human Serum N-glycome for Molecular Diagnostic Applications in Inflammatory and Malignant Lung Diseases
Volume: 20 Issue: 10
关键词: 人血清N-糖基化,去硅烷基化,毛细管电泳,肺疾病,分子诊断,恶性
摘要:
Background: Immunoglobulin G and A, transferrin, haptoglobin and alpha-1- antitrypsin represent approximately 85% of the human serum glycoproteome and their N-glycosylation analysis may lead to the discovery of important molecular disease markers. However, due to the labile nature of the sialic acid residues, the desialylated subset of the serum N-glycoproteome has been traditionally utilized for diagnostic applications.
Objective: Creating a five-protein model to deconstruct the overall N-glycosylation fingerprints in inflammatory and malignant lung diseases.
Methods: The N-glycan pool of human serum and the five high abundant serum glycoproteins were analyzed. Simultaneous endoglycosidase/sialidase digestion was followed by fluorophore labeling and separation by CE-LIF to establish the model. Pooled serum samples from patients with COPD, lung cancer (LC) and their comorbidity were all analyzed.
Results: Nine significant (>1%) asialo-N-glycan structures were identified both in human serum and the standard protein mixture. The core-fucosylated-agalacto-biantennary glycan differentiated COPD and LC and both from the control and the comorbidity groups. Decrease in the core-fucosylated-agalacto-biantennary-bisecting, monogalacto and bigalacto structures differentiated all disease groups from the control. The significant increase of the fucosylated-galactosylated-triantennary structure was highly specific for LC, to a medium extent for COPD and a lesser extent for comorbidity. Also, some increase in the afucosylated-galactosylated-biantennary structure in all three disease types and afucosylated-galactosylated-triantennary structures in COPD and LC were observed in comparison to the control group.
Conclusion: Our results suggested that changes in the desialylated human serum Nglycome hold glycoprotein specific molecular diagnostic potential for malignant and inflammatory lung diseases, which can be modeled with the five-protein mixture.
Export Options
About this article
Cite this article as:
Modeling of the Desialylated Human Serum N-glycome for Molecular Diagnostic Applications in Inflammatory and Malignant Lung Diseases, Current Molecular Medicine 2020; 20 (10) . https://dx.doi.org/10.2174/1566524020666200422085316
DOI https://dx.doi.org/10.2174/1566524020666200422085316 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
Current Medicinal Chemistry Molecular and Cellular Mechanisms of Hexavalent Chromium-Induced Lung Cancer: An Updated Perspective
Current Drug Metabolism Etoposide: Discovery and Medicinal Chemistry
Current Medicinal Chemistry Anticancer Metallotherapeutics in Preclinical Development
Current Medicinal Chemistry Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism
Current Pharmaceutical Design Nanotechnological Strategies to Improve Water Solubility of Commercially Available Drugs
Current Nanomedicine Interplay of Breast Cancer Resistance Protein (BCRP) and Metabolizing Enzymes
Current Drug Metabolism Eicosanoids in Prevention and Management of Diseases
Current Molecular Medicine Big Data to Knowledge: Application of Machine Learning to Predictive Modeling of Therapeutic Response in Cancer
Current Genomics Breast Cancer Detection and Classification using Traditional Computer Vision Techniques: A Comprehensive Review
Current Medical Imaging Reverse Screening Bioinformatics Approach to Identify Potential Anti Breast Cancer Targets Using Thymoquinone from Neutraceuticals Black Cumin Oil
Anti-Cancer Agents in Medicinal Chemistry Biomarker Assessment in Nutritional Modulation of Oxidative Stress-Induced Cancer Development by Lipid-Related Bioactive Molecules
Recent Patents on Anti-Cancer Drug Discovery Novel Implications for Lysophospholipids, Lysophosphatidic Acid and Sphingosine 1-Phosphate, as Drug Targets in Cancer
Anti-Cancer Agents in Medicinal Chemistry Psychoimmunological Analysis of Cancer Patients: Correlation with the Prognosis
Current Aging Science Novel Therapeutic Approaches Based on the Targeting of Microenvironment-Derived Survival Pathways in Human Cancer: Experimental Models and Translational Issues
Current Pharmaceutical Design Efficacy and Safety of Bevacizumab in Glioblastomas
Current Medicinal Chemistry Clinical Uses of Melatonin: Evaluation of Human Trials
Current Medicinal Chemistry Molecular Mechanisms and Potential Treatment Targets for Ovarian Cancer by Analyzing Transcriptional Regulatory Network
Letters in Drug Design & Discovery Radiolabeled Small Molecule Inhibitors of VEGFR - Recent Advances
Current Pharmaceutical Design Disintegrins from Snake Venoms and their Applications in Cancer Research and Therapy
Current Protein & Peptide Science